305 related articles for article (PubMed ID: 10980053)
1. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
Testa G; Crippin JS; Netto GJ; Goldstein RM; Jennings LW; Brkic BS; Brooks BK; Levy MF; Gonwa TA; Klintmalm GB
Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
[TBL] [Abstract][Full Text] [Related]
2. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
3. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
Sugo H; Balderson GA; Crawford DH; Fawcett J; Lynch SV; Strong RW; Futagawa S
Surg Today; 2003; 33(6):421-5. PubMed ID: 12768367
[TBL] [Abstract][Full Text] [Related]
4. Histological and clinical outcome after liver transplantation for hepatitis C.
Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
[TBL] [Abstract][Full Text] [Related]
5. Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: influence of immunosuppressive regimens.
Hunt J; Gordon FD; Lewis WD; Pomfret E; Pomposelli JJ; Jenkins RL; Khettry U
Liver Transpl; 2001 Dec; 7(12):1056-63. PubMed ID: 11753907
[TBL] [Abstract][Full Text] [Related]
6. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
[TBL] [Abstract][Full Text] [Related]
7. The natural history of hepatitis C cirrhosis after liver transplantation.
Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
[TBL] [Abstract][Full Text] [Related]
8. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
Schmeding M; Neumann UP; Puhl G; Bahra M; Neuhaus R; Neuhaus P
Liver Transpl; 2007 May; 13(5):687-92. PubMed ID: 17457911
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
[TBL] [Abstract][Full Text] [Related]
12. Retransplantation for recurrent hepatitis C.
Ghobrial RM
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S38-43. PubMed ID: 12362296
[TBL] [Abstract][Full Text] [Related]
13. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression.
Alkhouri N; Hanouneh IA; Lopez R; Zein NN
Liver Transpl; 2010 Feb; 16(2):155-62. PubMed ID: 20104483
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of the impact of immunosuppression on the course of recurrent hepatitis C after liver transplantation.
Bahr MJ; Beckermann JG; Rifai K; Gehrmann L; Rosenau J; Klempnauer J; Strassburg CP; Manns MP
Transplant Proc; 2005 May; 37(4):1703-4. PubMed ID: 15919437
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
[TBL] [Abstract][Full Text] [Related]
16. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
[TBL] [Abstract][Full Text] [Related]
17. Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.
Zimmermann T; Otto C; Hoppe-Lotichius M; Biesterfeld S; Lautem A; Knaak M; Zimmermann A; Barreiros AP; Heise M; Schattenberg JM; Sprinzl MF; Galle PR; Otto G; Schuchmann M
Transplant Proc; 2009; 41(6):2549-56. PubMed ID: 19715972
[TBL] [Abstract][Full Text] [Related]
18. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
[TBL] [Abstract][Full Text] [Related]
19. Risk factors in liver retransplantation: a single-center experience.
Crivellin C; De Martin E; Germani G; Gambato M; Senzolo M; Russo FP; Vitale A; Zanus G; Cillo U; Burra P
Transplant Proc; 2011 May; 43(4):1110-3. PubMed ID: 21620065
[TBL] [Abstract][Full Text] [Related]
20. The natural history of recurrent hepatitis C and what influences this.
Gane EJ
Liver Transpl; 2008 Oct; 14 Suppl 2():S36-44. PubMed ID: 18825724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]